Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol
- PMID: 7146618
Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol
Abstract
The relationship of the magnitude and persistence of elevated striatal dopamine receptor binding sites to the dose and duration of haloperidol treatment has been examined in rats. The magnitude of elevation was found to be significantly related both to dose and duration of dose. The persistence of statistically significant receptor binding elevation, after withdrawal, was estimated to be 0.67 days/day on haloperidol. Receptor binding was carried out with 3H-spiroperidol.
Similar articles
-
[Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].Biull Eksp Biol Med. 1984 Oct;98(10):444-6. Biull Eksp Biol Med. 1984. PMID: 6541951 Russian.
-
Aging and the regulation of striatal dopaminergic mechanisms in mice.J Pharmacol Exp Ther. 1981 Dec;219(3):695-700. J Pharmacol Exp Ther. 1981. PMID: 7197719
-
Chronic haloperidol does not increase specific dopamine receptor binding in rat frontal cortex.Res Commun Chem Pathol Pharmacol. 1982 Sep;37(3):323-32. Res Commun Chem Pathol Pharmacol. 1982. PMID: 7178646
-
Chronic neuroleptic treatment and dopamine receptor regulation.Adv Biochem Psychopharmacol. 1980;24:89-94. Adv Biochem Psychopharmacol. 1980. PMID: 6105809 Review. No abstract available.
-
Adaptive changes in brain dopamine function as a result of neuroleptic treatment.Adv Neurol. 1988;49:417-31. Adv Neurol. 1988. PMID: 2894127 Review. No abstract available.
Cited by
-
Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.Psychopharmacology (Berl). 1989;99(1):109-16. doi: 10.1007/BF00634463. Psychopharmacology (Berl). 1989. PMID: 2506596
-
Neuroleptic-induced striatal dopamine receptor supersensitivity in mice: relationship to dose and drug.Psychopharmacology (Berl). 1984;84(1):115-9. doi: 10.1007/BF00432038. Psychopharmacology (Berl). 1984. PMID: 6149590